FXN gene | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,334 results for “FXN gene”

Trials

View all 4517 →

Biomarker for Friedreich's Ataxia (BioFridA)

1,000 participants · First posted Sep 16, 2020

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

25 participants · First posted Mar 31, 2022

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

31 participants · First posted Jun 10, 2025

Drugs

View all 1876 →

FXN gene therapy (AavantiBio)

FXN gene therapy (Pfizer)

FXN Gene Therapy(Voyager Therapeutics)

Organizations

View all 59 →

JIUYUAN GENE

Triple-Gene LLC

United States

MOMOTARO-GENE INC.

Japan

News

View all 4882 →

Novel Gene Therapy Shows Safety and Early Efficacy Signals in Friedreich Ataxia Cardiomyopathy Phase 1 Trial

Solid Biosciences' SGT-212 Receives FDA Fast Track Designation for Friedreich's Ataxia Treatment

Larimar Therapeutics' Nomlabofusp Shows Promise in Friedreich's Ataxia Studies

Page 1 of 1134